US Stock MarketDetailed Quotes

TPST Tempest Therapeutics

Watchlist

1.440
-0.110-7.10%

Close Aug 16 16:00 ET

1.420
-0.020-1.39%

Post 20:01 ET

36.30MMarket Cap-900P/E (TTM)

Tempest Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tempest Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Tempest Therapeutics Earnings Reports

Tempest Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 16:50 ET

Tempest Therapeutics | 10-Q: Q1 2024 Earnings Report

May 9 16:35 ET

Tempest Therapeutics | 10-K: FY2023 Annual Report

Mar 19 16:41 ET

Tempest Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 8, 2023 17:25 ET

Analyst Rating

Updated: Aug 17, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall